The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     


Drug Intelligence & Clinical Pharmacy: Vol. 16, No. 11, pp. 817-822.
© 1982 Harvey Whitney Books Company.
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cummings, D.
Right arrow Articles by Vlasses, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cummings, D.
Right arrow Articles by Vlasses, P.


Research Articles

Antihypertensive drug withdrawal syndrome

DM Cummings and PH Vlasses

After discontinuation of antihypertensive medications, patients may experience symptoms associated with catecholamine excess, with or without a rapid rise in blood pressure; this is referred to as antihypertensive drug withdrawal syndrome. Though most often associated with the discontinuation of clonidine, this syndrome has been reported to follow the withdrawal of many other antihypertensives. Proposed mechanisms for the syndrome, depending on the drug involved, include enhanced activity of (1) the sympathoadrenal system, (2) the renin-angiotensin-aldosterone system, and (3) the thyroid hormones. The typical patient at risk is a younger person with severe hypertension, who has been on multiple drugs in high doses for a long period. Guidelines are provided for minimizing the occurrence of the syndrome and for treating the reaction, should it occur.


This article has been cited by other articles:


Home page
Br J AnaesthHome page
M. P. Shelly
Editorial I: Dexmedetomidine: a real innovation or more of the same?
Br. J. Anaesth., November 1, 2001; 87(5): 677 - 678.
[Full Text] [PDF]


Home page
Arch Fam MedHome page
J. K. Kirk and S. H. Johnson
Safe Discontinuation of Antihypertensive Therapy
Arch Fam Med, March 1, 1995; 4(3): 266 - 270.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
R. K. FERGUSON and P. H. VLASSES
How Urgent Is 'Urgent' Hypertension?
Arch Intern Med, February 1, 1989; 149(2): 257 - 258.
[Abstract] [PDF]


Home page
Hum Exp ToxicolHome page
M.D.B. Stephens
Drug-induced Piloerection in Man: an {alpha}1-Adrenoceptor Agonist Effect?
Human and Experimental Toxicology, September 1, 1986; 5(5): 319 - 324.
[Abstract] [PDF]




homecopy help contact us subscription past issues search current issue
Copyright © 1982 by Harvey Whitney Books Company.